Skip to main content

Rousseau Jon B's Form 4 filing

BrightSpring Health Services, Inc. (BTSG) · filed Mar 6, 2026

Accession no.
0000908834-26-000128
Filed
Mar 6, 2026
Trade date
Mar 4-5, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $9.05M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rousseau Jon BCIK 0001579775Director, Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 4, 2026Common StockMOption exerciseAcquired+220,000$6.37+$1,401,4001,243,880Direct
Mar 4, 2026Common StockSSaleDisposed−220,000$41.15F1−$9,053,0001,023,880Direct
Mar 5, 2026Common StockAGrant or awardAcquired+186,845$0.00$01,210,725Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 4, 2026Common StockAGrant or awardAcquired+955,823$0.00$01,516,064Direct
Mar 4, 2026Common StockMOption exerciseDisposed−220,000$0.00$01,296,064Direct
Mar 5, 2026Common StockAGrant or awardAcquired+458,008$0.00$0458,008Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.

Referenced by the price of 1 transaction in Table I.

Remarks

Title: Chairman, President and Chief Executive Officer

Read the full filing on SEC EDGAR (opens in a new tab)